Core Products and Biological Matrices

Human Biospecimens

BioIVT maintains a vast repository of human biological materials, categorized into "Normal" and "Disease State" specimens. These are used primarily for biomarker discovery, target validation, and diagnostic development.

• Human Biofluids: This includes whole blood, serum, plasma, urine, cerebrospinal fluid (CSF), synovial fluid, and saliva. These can be collected from specific donor profiles based on age, gender, ethnicity, or clinical history.
• Disease State Tissues: Through a global network of clinical sites, BioIVT procures tissues across major therapeutic areas, most notably oncology. Their inventory includes formal-fixed paraffin-embedded (FFPE) blocks, fresh frozen tissues, and Tissue Microarrays (TMAs).
• Clinical Data Integration: A key differentiator for BioIVT is the association of biospecimens with detailed clinical data, including treatment history, pathology reports, and longitudinal follow-up, which is essential for precision medicine research.

Animal Products

To support preclinical research and cross-species comparisons, BioIVT provides a comprehensive range of animal-derived products from common laboratory species (rat, mouse, primate, canine, etc.).

• Control Biofluids and Tissues: Standardized collection of blood, organs, and specialized tissues to serve as control groups in experimental designs.
• Custom Collections: BioIVT offers bespoke collection services where researchers can specify the anticoagulant, volume, or processing method required for their specific animal model studies.

Specialized Cellular Products

Primary Cells and Hepatocytes

BioIVT is widely recognized as a market leader in the production of high-quality hepatocytes, which are the gold standard for in vitro testing of drug metabolism and pharmacokinetics (DMPK).

• Cryopreserved Hepatocytes: Available in "Transporter-Certified" and "Induction-Certified" formats, these cells allow researchers to evaluate how a drug is metabolized by the liver.
• Non-Parenchymal Cells: This includes Kupffer cells, stellate cells, and liver sinusoidal endothelial cells, which are increasingly used in complex 3D co-culture models to mimic the human liver microenvironment.
• Immune Cells: The company provides isolated human peripheral blood mononuclear cells (PBMCs), as well as purified subsets like T-cells, B-cells, and Natural Killer (NK) cells, vital for immuno-oncology research.

Subcellular Fractions

To support biochemical assays, BioIVT produces subcellular fractions from various tissues: * Microsomes and S9 Fractions: Used to study metabolic stability and metabolite profiling. * Cytosol and Lysosomes: Specialized fractions for niche metabolic pathways.

Research Services and Laboratory Capabilities

Beyond hardware and specimens, BioIVT operates as a Contract Research Organization (CRO) providing specialized laboratory services.

ADME and Tox Research Services

BioIVTâ??s Phase-Zero services allow pharmaceutical companies to outsource critical assays to experts. * Metabolic Stability Screening: Determining the half-life of drug candidates. * Drug-Drug Interaction (DDI) Studies: Assessing whether a new drug will interfere with the metabolism of existing medications via CYP450 inhibition or induction. * Transporter Assays: Investigating how drugs are moved into and out of cells.

Histology and Pathology Services

The company employs board-certified pathologists to provide expert analysis for tissue-based research. * Immunohistochemistry (IHC): Custom protocol development and staining to visualize protein expression in tissue sections. * In Situ Hybridization (ISH): Detecting specific nucleic acid sequences within cells. * Digital Pathology: High-resolution scanning and image analysis for quantitative data extraction from tissue slides.

Compliance, Ethics, and Quality Assurance

A fundamental aspect of BioIVTâ??s operations is its rigorous adherence to ethical standards. The company operates under strict Institutional Review Board (IRB) and Independent Ethics Committee (IEC) approvals.

• Informed Consent: All human specimens are obtained with documented donor consent, ensuring legal and ethical compliance for downstream commercial research.
• Traceability: BioIVT maintains a robust chain of custody for every specimen, from the point of collection to final delivery.
• Quality Management: The company adheres to ISO 9001 standards and maintains GxP-compliant facilities where necessary, ensuring that the biological materials meet the high-reproducibility requirements of the pharmaceutical industry.

Strategic Role in the Industry

BioIVT functions as a foundational partner for the "Virtual Pharma" model and traditional large-scale R&D departments. By providing "fit-for-purpose" biospecimens, they reduce the time and logistical burden associated with sample procurement. Their ability to provide matched sets (e.g., tumor tissue, adjacent normal tissue, and blood from the same donor) is particularly valuable for genomic and proteomic studies seeking to identify specific disease drivers.